In 2015, ICBC Credit Suisse Asset Management Co., Ltd., a joint venture controlled by ICBC, significantly increased the asset size under management while keeping up good performance in both equity and bond assets by strengthening market research, product innovation and reasonably allocating assets. Statistics show, the annual return rates of 13 funds managed by the company ranked among the top ten of funds of the same types, of which seven were ranked among the top three of their respective categories. By the end of 2015, the total assets managed by the company (including public funds and special accounts) amounted to around RMB 930 billion, up nearly 60% over the beginning of the year.

In terms of equity products, 16 domestic equity funds issued by ICBC Credit Suisse Asset Management before 2015 posted an annual average yield of over 40%, around 35 percentage points higher than that of CSI 300 Index, including six funds that had a return rate of over 50%. ICBCCS Health Care Industry Equity Fund ranked 2nd among equity funds of the healthcare industry with a return rate of 59.3%; ICBCCS Selected and Balanced Hybrid Equity Fund ranked 3rd among funds of the same type for posting a growth rate of 58.5%. ICBCCS Global Selective Equity Fund and ICBCCS Global China Opportunity Equity Fund, two equity-based QDII products, ranked 1st and 2nd with a total return rate of 15.58% and 10.30% respectively, and took the first three places among funds of the same category for three consecutive years.

In terms of fixed income products, thanks to its extensive product lines, the company provided investors with diversified options by shifting investment directions in variance with the market in 2015, reflecting advantages amid volatile market conditions. 20 of its bond funds posted an annual average yield of over 12%.